Children with newly diagnosed immune thrombocytopenia (ITP) treated with eltrombopag as a frontline therapy show significantly improved platelet responses and other outcomes compared with the standard ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback